Product Information

RIZATRIPTAN 5 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.3437 per EA under NDC 57237008763. Its NADAC has been published 484 times since Aug 9, 2017.

FDA first approved this application on Dec 31, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

RIZATRIPTAN 5 MG TABLET

Rizatriptan Benzoate
$0.3437per EA

Strength

5 mg/1

NDC

57237008763

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

RIZATRIPTAN BENZOATE

Approval Type

Generic (ANDA)

FDA Application

ANDA202490

FDA Approved

12/31/2012

TE Code

AB

On Market Since

12/31/2012

Pharmacological Classes

Serotonin 1b Receptor Agonists
Serotonin 1d Receptor Agonists
Serotonin-1b and Serotonin-1d Receptor Agonist

Price Statistics

The NADAC for RIZATRIPTAN 5 MG TABLET has been published 484 times since Aug 9, 2017, and over the history we have for it it has declined 67.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3437 per EA
All-time high$1.0560 (Aug 16, 2017)
All-time low$0.3203 (Jul 17, 2024)
52-week high$0.5666
52-week low$0.3437
Median price$0.6106
Average price$0.6503
Largest weekly change+74.4% (Aug 21, 2024)
Weeks tracked484
Tracking sinceAug 9, 2017

Price History

1W

0.0%

1M

-1.2%

3M

-0.3%

6M

-25.7%

1Y

-34.4%

3Y

-28.9%

5Y

-52.7%

All

-67.4%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 7% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of RIZATRIPTAN 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for RIZATRIPTAN 5 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.3437 per EA (NDC 57237008763), effective Nov 11, 2026.

How has the price of RIZATRIPTAN 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for RIZATRIPTAN 5 MG TABLET has declined 67.4%. It has been tracked across 484 weekly CMS publications since Aug 9, 2017.

What are the highest and lowest recorded NADAC prices for RIZATRIPTAN 5 MG TABLET?

Since Aug 9, 2017, the NADAC for RIZATRIPTAN 5 MG TABLET has ranged from a low of $0.3203 (Jul 17, 2024) to a high of $1.0560 (Aug 16, 2017), with a median of $0.6106 per EA.

Are there cheaper alternatives to RIZATRIPTAN 5 MG TABLET?

Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, RIZATRIPTAN 5 MG TABLET, is $0.3203 per EA — about 7% below RIZATRIPTAN 5 MG TABLET.

Who manufactures RIZATRIPTAN 5 MG TABLET?

RIZATRIPTAN 5 MG TABLET (NDC 57237008763) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.